Shu-Feng Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shu-Feng Zhou has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
- Guowu Zhan
Huaqiao University
8 shared publications Zhi-Wei Zhou
Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, 33612, USA
7 shared publications- Rui Pei
College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang 330045, China
6 shared publications - Dan Zi
Department of Gynecology and Obstetrics, Guizhou Provincial People’s Hospital, Guiyang, China
5 shared publications Libing Tian
College of Chemical Engineering, Huaqiao University, Xiamen, 361021, People’s Republic of China
5 shared publications- Wei Jiang
College of Chemical Engineering, Huaqiao University, Xiamen, Fujian 361021, PR China
5 shared publications
Latest Publications
- 4 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 9 (23) , 10927-10939
Tumor Microenvironment-Responsive Integrated Nanosystems for Enhanced Cuproptosis/Ferroptosis Anticancer Therapy
- 4 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 9 (23) , 10927-10939
Tumor Microenvironment-Responsive Integrated Nanosystems for Enhanced Cuproptosis/Ferroptosis Anticancer Therapy
- Open Access
- 14 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (8) , 3495
Correction: Zi et al. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells. Int. J. Mol. Sci. 2015, 16, 27228–27251
- 14 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (8) , 3495
Open AccessCorrection: Zi et al. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells. Int. J. Mol. Sci. 2015, 16, 27228–27251
- Open Access
- 10 December 2025
- Published by Open Access Lance Limited in Journal of Biomedicine and Big Data
- Vol. 1 (1) , 16-34
Exploring the potential value of aloe active components in inhibiting non-small cell lung cancer through network pharmacology
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide, and its management is challenged by profound molecular heterogeneity and inevitable resistance to targeted therapies. Natural products offer a valuable reservoir for anticancer drug discovery, yet the therapeutic potential of Aloe vera—a medicinal plant rich in structurally diverse bioactive compounds—remains insufficiently characterised in the context of NSCLC. Here, we employed an integrated strategy combining network pharmacology, protein–protein interaction analysis, Gene Ontology and KEGG enrichment, molecular docking, and 100-ns molecular dynamics simulations to comprehensively elucidate the multi-target and multi-pathway regulatory mechanisms of Aloe vera active constituents against NSCLC. We identified 369 aloe-derived targets and 5519 NSCLC-related genes, with 268 overlapping targets enriched in pathways involving EGFR signalling, PI3K/AKT/mTOR activation, p53 regulation, inflammation, apoptosis, and drug-resistance networks. Core hub genes included TP53, EGFR, AKT1, and STAT3. Molecular docking demonstrated strong spontaneous binding between key aloe compounds (such as aloe-emodin, aloeresin C, quercetin and sitosterols) and wild-type EGFR, mutant EGFR T790M/C797S, AKT1, and p53. Molecular dynamics simulations confirmed stable ligand–protein interactions, favourable hydrogen-bonding networks, and energetically favourable binding free energies. Collectively, our findings reveal a systematic, multi-level regulatory landscape through which Aloe vera may exert anti-NSCLC effects and highlight several candidate molecules with potential to enhance therapeutic efficacy or overcome EGFR-TKI resistance. This study provides a solid theoretical framework for subsequent experimental validation and the development of novel aloe-derived anticancer agents with low toxicity.
- 10 December 2025
- Published by Open Access Lance Limited in Journal of Biomedicine and Big Data
- Vol. 1 (1) , 16-34
Open AccessExploring the potential value of aloe active components in inhibiting non-small cell lung cancer through network pharmacology
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide, and its management is challenged by profound molecular heterogeneity and inevitable resistance to targeted therapies. Natural products offer a valuable reservoir for anticancer drug discovery, yet the therapeutic potential of Aloe vera—a medicinal plant rich in structurally diverse bioactive compounds—remains insufficiently characterised in the context of NSCLC. Here, we employed an integrated strategy combining network pharmacology, protein–protein interaction analysis, Gene Ontology and KEGG enrichment, molecular docking, and 100-ns molecular dynamics simulations to comprehensively elucidate the multi-target and multi-pathway regulatory mechanisms of Aloe vera active constituents against NSCLC. We identified 369 aloe-derived targets and 5519 NSCLC-related genes, with 268 overlapping targets enriched in pathways involving EGFR signalling, PI3K/AKT/mTOR activation, p53 regulation, inflammation, apoptosis, and drug-resistance networks. Core hub genes included TP53, EGFR, AKT1, and STAT3. Molecular docking demonstrated strong spontaneous binding between key aloe compounds (such as aloe-emodin, aloeresin C, quercetin and sitosterols) and wild-type EGFR, mutant EGFR T790M/C797S, AKT1, and p53. Molecular dynamics simulations confirmed stable ligand–protein interactions, favourable hydrogen-bonding networks, and energetically favourable binding free energies. Collectively, our findings reveal a systematic, multi-level regulatory landscape through which Aloe vera may exert anti-NSCLC effects and highlight several candidate molecules with potential to enhance therapeutic efficacy or overcome EGFR-TKI resistance. This study provides a solid theoretical framework for subsequent experimental validation and the development of novel aloe-derived anticancer agents with low toxicity.
- Open Access
- 27 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11467
Correction: Zi et al. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells. Int. J. Mol. Sci. 2015, 16, 27228–27251
- 27 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11467
Open AccessCorrection: Zi et al. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells. Int. J. Mol. Sci. 2015, 16, 27228–27251
- 27 September 2025
- Published by Elsevier in Cancer Letters
- Vol. 633, 218039
Corrigendum to “Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells” [Cancer. Lett. (382) 2016-11-28; 382(2):215–230]
- 27 September 2025
- Published by Elsevier in Cancer Letters
- Vol. 633, 218039
Corrigendum to “Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells” [Cancer. Lett. (382) 2016-11-28; 382(2):215–230]
- 6 March 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 264 (Pt 2) , 130691
Multi-strategy orthogonal enhancement and analysis of aldo-keto reductase thermal stability
- 6 March 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 264 (Pt 2) , 130691
Multi-strategy orthogonal enhancement and analysis of aldo-keto reductase thermal stability
- 13 September 2023
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 171, 110326
Specific coenzyme preference switching for an aldo-keto reductase that synthesizes the chiral intermediate of duloxetine
- 13 September 2023
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 171, 110326
Specific coenzyme preference switching for an aldo-keto reductase that synthesizes the chiral intermediate of duloxetine
- Open Access
- 15 May 2023
- Published by Impact Journals, LLC in Aging
- Vol. 15 (9) , 3891-3892
Correction for: CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma
- 15 May 2023
- Published by Impact Journals, LLC in Aging
- Vol. 15 (9) , 3891-3892
Open AccessCorrection for: CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma
- Open Access
- 27 February 2023
- Published by MDPI AG in Biosensors
- Vol. 13 (3) , 327
A Minireview for Recent Development of Nanomaterial-Based Detection of Antibiotics
Antibiotics are considered a new type of organic pollutant. Antibiotic residues have become a global issue due to their harm to human health. As the use of antibiotics is increasing in human life, such as in medicine, crops, livestock, and even drinking water, the accurate analysis of antibiotics is very vital. In order to develop rapid and on-site approaches for the detection of antibiotics and the analysis of trace-level residual antibiotics, a high-sensitivity, simple, and portable solution is required. Meanwhile, the rapid nanotechnology development of a variety of nanomaterials has been achieved. In this review, nanomaterial-based techniques for antibiotic detection are discussed, and some reports that have employed combined nanomaterials with optical techniques or electrochemical techniques are highlighted.
- 27 February 2023
- Published by MDPI AG in Biosensors
- Vol. 13 (3) , 327
Open AccessA Minireview for Recent Development of Nanomaterial-Based Detection of Antibiotics
Antibiotics are considered a new type of organic pollutant. Antibiotic residues have become a global issue due to their harm to human health. As the use of antibiotics is increasing in human life, such as in medicine, crops, livestock, and even drinking water, the accurate analysis of antibiotics is very vital. In order to develop rapid and on-site approaches for the detection of antibiotics and the analysis of trace-level residual antibiotics, a high-sensitivity, simple, and portable solution is required. Meanwhile, the rapid nanotechnology development of a variety of nanomaterials has been achieved. In this review, nanomaterial-based techniques for antibiotic detection are discussed, and some reports that have employed combined nanomaterials with optical techniques or electrochemical techniques are highlighted.
- 11 February 2023
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 52 (12) , 3661-3670
Fabrication of supported Pt/CeO2 nanocatalysts doped with different elements for CO oxidation: theoretical and experimental studies
Herein, element-doped Pt/CeO2 nanocatalysts were fabricated using MOFs as precursors, which were evaluated towards CO oxidation by theoretical and experimental studies.
- 11 February 2023
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 52 (12) , 3661-3670
Fabrication of supported Pt/CeO2 nanocatalysts doped with different elements for CO oxidation: theoretical and experimental studies
Herein, element-doped Pt/CeO2 nanocatalysts were fabricated using MOFs as precursors, which were evaluated towards CO oxidation by theoretical and experimental studies.